CN105228984A - 硝羟喹啉碱加成盐及其用途 - Google Patents
硝羟喹啉碱加成盐及其用途 Download PDFInfo
- Publication number
- CN105228984A CN105228984A CN201480025681.5A CN201480025681A CN105228984A CN 105228984 A CN105228984 A CN 105228984A CN 201480025681 A CN201480025681 A CN 201480025681A CN 105228984 A CN105228984 A CN 105228984A
- Authority
- CN
- China
- Prior art keywords
- urocoli
- salt
- amine
- base addition
- addition salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
Abstract
Description
Claims (25)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361790059P | 2013-03-15 | 2013-03-15 | |
US61/790,059 | 2013-03-15 | ||
PCT/US2014/030532 WO2014145723A1 (en) | 2013-03-15 | 2014-03-17 | Base addition salts of nitroxoline and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105228984A true CN105228984A (zh) | 2016-01-06 |
CN105228984B CN105228984B (zh) | 2018-03-23 |
Family
ID=51538074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480025681.5A Active CN105228984B (zh) | 2013-03-15 | 2014-03-17 | 硝羟喹啉碱加成盐及其用途 |
Country Status (12)
Country | Link |
---|---|
US (1) | US9758484B2 (zh) |
EP (1) | EP2970128B1 (zh) |
JP (1) | JP6273349B2 (zh) |
KR (1) | KR20160021077A (zh) |
CN (1) | CN105228984B (zh) |
AU (2) | AU2014232722B2 (zh) |
BR (1) | BR112015022849B1 (zh) |
CA (1) | CA2907338C (zh) |
ES (1) | ES2766758T3 (zh) |
HK (1) | HK1214589A1 (zh) |
MX (1) | MX357888B (zh) |
WO (1) | WO2014145723A1 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109310757A (zh) * | 2016-03-31 | 2019-02-05 | 爱西里斯药物技术有限公司 | 硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途 |
CN111773193A (zh) * | 2020-07-03 | 2020-10-16 | 江苏亚虹医药科技有限公司 | 含硝羟喹啉赖氨酸盐的药物组合物及其制备方法和用途 |
CN111960998A (zh) * | 2020-08-03 | 2020-11-20 | 江苏亚虹医药科技有限公司 | 硝羟喹啉衍生物及其制备方法和用途 |
WO2021023231A1 (zh) * | 2019-08-05 | 2021-02-11 | 江苏亚虹医药科技股份有限公司 | 含硝羟喹啉的药物组合物、硝羟喹啉口服固体片剂及其制备方法和用途 |
WO2021136381A1 (zh) | 2019-12-31 | 2021-07-08 | 江苏亚虹医药科技股份有限公司 | 含硝羟喹啉的药物组合物、硝羟喹啉片剂及其制备方法和用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2745834A (en) * | 1953-02-09 | 1956-05-15 | Phillips Petroleum Co | Stabilization of certain vinyl-pyridines, vinyl quinolines and vinyl-isoquinolines |
WO2005063711A1 (en) * | 2003-12-26 | 2005-07-14 | Nissan Chemical Industries, Ltd. | Crystal form of quinoline compound and process for its production |
WO2010136105A2 (en) * | 2009-05-28 | 2010-12-02 | Merck Patent Gmbh | Ammoniumcarboxylates |
CN102239149A (zh) * | 2008-10-06 | 2011-11-09 | 约翰·霍普金斯大学 | 喹啉化合物作为血管新生、人类甲硫氨酰氨肽酶、以及sirt1的抑制剂,以及治疗病症的方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2745832A (en) * | 1954-03-08 | 1956-05-15 | Nuodex Products Co Inc | Metal quinolinolates and methods of making the same |
US3872128A (en) | 1972-03-08 | 1975-03-18 | Union Carbide Corp | Antimicrobial hydroxy quinoline, ethylene-acrylic polymer compositions |
JPS5768831A (en) | 1980-10-17 | 1982-04-27 | Fuji Photo Film Co Ltd | Heat developable photosensitive material |
JPS57101835A (en) | 1980-12-17 | 1982-06-24 | Fuji Photo Film Co Ltd | Thermodevelopable photosensitive material |
US4329185A (en) | 1981-01-21 | 1982-05-11 | Dso "Pharmachim" | Method for the preparation of a biologically active polyamide net |
US5242892A (en) | 1984-07-27 | 1993-09-07 | The Board Of Trustees Of The University Of Illinois | Chlorophyll biosynthesis modulators |
JPH03284734A (ja) | 1990-03-31 | 1991-12-16 | Toshiba Corp | 有機非線形光学材料 |
IT1317735B1 (it) | 2000-01-26 | 2003-07-15 | Nicox Sa | Sali di agenti antimicrobici. |
US7511137B2 (en) * | 2003-12-19 | 2009-03-31 | Rigel Pharmaceuticals, Inc. | Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates |
WO2006117660A2 (en) | 2005-05-04 | 2006-11-09 | Clio Pharmaceutical Corporation | Method for treating cancer, coronary, inflammatory and macular disease, combining the modulation of zinc- and/or copper dependent proteins |
EP2853600B1 (en) | 2005-05-11 | 2018-09-19 | ETH Zürich | Recombinant N-glycosylated proteins from procaryotic cells |
EP1892248A1 (en) | 2006-08-21 | 2008-02-27 | Eidgenössische Technische Hochschule Zürich | Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
JP2010070557A (ja) | 2009-12-17 | 2010-04-02 | Anacor Pharmaceuticals Inc | 加水分解抵抗性ホウ素含有治療薬および使用法 |
EP2353599A1 (en) | 2010-01-28 | 2011-08-10 | University of Ljubljana | 8-hydroxyquinolines as inhibitors of cathepsin B |
DK2730123T3 (da) * | 2011-07-07 | 2020-03-02 | Ericsson Telefon Ab L M | Overleveringsbeslutning i betjenende basisstation baseret på en første og anden type mobilitetsmekanisme |
-
2014
- 2014-03-17 JP JP2016503414A patent/JP6273349B2/ja active Active
- 2014-03-17 WO PCT/US2014/030532 patent/WO2014145723A1/en active Application Filing
- 2014-03-17 US US14/777,185 patent/US9758484B2/en active Active
- 2014-03-17 CA CA2907338A patent/CA2907338C/en active Active
- 2014-03-17 AU AU2014232722A patent/AU2014232722B2/en active Active
- 2014-03-17 MX MX2015012720A patent/MX357888B/es active IP Right Grant
- 2014-03-17 CN CN201480025681.5A patent/CN105228984B/zh active Active
- 2014-03-17 ES ES14762230T patent/ES2766758T3/es active Active
- 2014-03-17 EP EP14762230.2A patent/EP2970128B1/en active Active
- 2014-03-17 BR BR112015022849-6A patent/BR112015022849B1/pt active IP Right Grant
- 2014-03-17 KR KR1020157028976A patent/KR20160021077A/ko active Search and Examination
-
2016
- 2016-03-02 HK HK16102445.9A patent/HK1214589A1/zh unknown
-
2017
- 2017-02-07 AU AU2017200820A patent/AU2017200820A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2745834A (en) * | 1953-02-09 | 1956-05-15 | Phillips Petroleum Co | Stabilization of certain vinyl-pyridines, vinyl quinolines and vinyl-isoquinolines |
WO2005063711A1 (en) * | 2003-12-26 | 2005-07-14 | Nissan Chemical Industries, Ltd. | Crystal form of quinoline compound and process for its production |
CN102239149A (zh) * | 2008-10-06 | 2011-11-09 | 约翰·霍普金斯大学 | 喹啉化合物作为血管新生、人类甲硫氨酰氨肽酶、以及sirt1的抑制剂,以及治疗病症的方法 |
WO2010136105A2 (en) * | 2009-05-28 | 2010-12-02 | Merck Patent Gmbh | Ammoniumcarboxylates |
Non-Patent Citations (2)
Title |
---|
CHRISTOPHE PELLETIER ET AL: "Roles of Divalent Cations and pH in Mechanism of Action of Nitroxoline against Escherichia coli Strains", 《ANTIMICROBIAL AGENTS AND CHEMOTHERAPY》 * |
PUBCHEM: "Compound Summary for:CID 70976725,Nitroxioline hexamethylenetetramine salt", 《PUBCHEM COMPOUND DATABASE》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109310757A (zh) * | 2016-03-31 | 2019-02-05 | 爱西里斯药物技术有限公司 | 硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途 |
US11324739B2 (en) | 2016-03-31 | 2022-05-10 | Jiangsu Yahong Meditech Co., Ltd. | Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers |
WO2021023231A1 (zh) * | 2019-08-05 | 2021-02-11 | 江苏亚虹医药科技股份有限公司 | 含硝羟喹啉的药物组合物、硝羟喹啉口服固体片剂及其制备方法和用途 |
WO2021136381A1 (zh) | 2019-12-31 | 2021-07-08 | 江苏亚虹医药科技股份有限公司 | 含硝羟喹啉的药物组合物、硝羟喹啉片剂及其制备方法和用途 |
CN114555059A (zh) * | 2019-12-31 | 2022-05-27 | 江苏亚虹医药科技股份有限公司 | 含硝羟喹啉的药物组合物、硝羟喹啉片剂及其制备方法和用途 |
CN111773193A (zh) * | 2020-07-03 | 2020-10-16 | 江苏亚虹医药科技有限公司 | 含硝羟喹啉赖氨酸盐的药物组合物及其制备方法和用途 |
WO2022001512A1 (zh) * | 2020-07-03 | 2022-01-06 | 江苏亚虹医药科技股份有限公司 | 含硝羟喹啉赖氨酸盐的药物组合物及其制备方法和用途 |
CN115768411A (zh) * | 2020-07-03 | 2023-03-07 | 江苏亚虹医药科技股份有限公司 | 含硝羟喹啉赖氨酸盐的药物组合物及其制备方法和用途 |
CN111960998A (zh) * | 2020-08-03 | 2020-11-20 | 江苏亚虹医药科技有限公司 | 硝羟喹啉衍生物及其制备方法和用途 |
WO2022028321A1 (zh) * | 2020-08-03 | 2022-02-10 | 江苏亚虹医药科技股份有限公司 | 硝羟喹啉衍生物及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
ES2766758T3 (es) | 2020-06-15 |
CA2907338C (en) | 2019-09-17 |
EP2970128B1 (en) | 2019-12-04 |
JP6273349B2 (ja) | 2018-01-31 |
KR20160021077A (ko) | 2016-02-24 |
CN105228984B (zh) | 2018-03-23 |
AU2014232722B2 (en) | 2017-03-09 |
MX2015012720A (es) | 2016-06-21 |
US20160031819A1 (en) | 2016-02-04 |
AU2014232722A1 (en) | 2015-09-24 |
WO2014145723A1 (en) | 2014-09-18 |
AU2017200820A1 (en) | 2017-03-02 |
BR112015022849A2 (pt) | 2017-12-26 |
MX357888B (es) | 2018-07-27 |
EP2970128A4 (en) | 2016-11-30 |
HK1214589A1 (zh) | 2016-07-29 |
EP2970128A1 (en) | 2016-01-20 |
CA2907338A1 (en) | 2014-09-18 |
BR112015022849B1 (pt) | 2020-02-18 |
JP2016514705A (ja) | 2016-05-23 |
US9758484B2 (en) | 2017-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6778512B2 (ja) | 複素環式化合物またはその使用 | |
CN101641339B (zh) | 用于预防和治疗心血管疾病的化合物 | |
CN110049982A (zh) | 杂环fxr调节剂 | |
CN105228984A (zh) | 硝羟喹啉碱加成盐及其用途 | |
TWI568728B (zh) | 雜環化合物及彼之用途 | |
CN104395319A (zh) | 用作ampk的活化剂的噻吩并吡啶酮衍生物 | |
CN1823071B (zh) | 用作钾通道抑制剂的噻吩并嘧啶衍生物 | |
JP7017523B2 (ja) | 代謝性疾患および癌の治療のための新規のミトコンドリア脱共役剤 | |
CN101902911A (zh) | 杂芳基化合物和其用途 | |
CN106573937A (zh) | 作为fshr调节剂的吡唑化合物及其用途 | |
CN103228651A (zh) | 可用作atr激酶抑制剂的化合物 | |
CN101848909A (zh) | 可用作蛋白激酶抑制剂的吡咯并[3,2-c]吡啶 | |
CN101801959A (zh) | 可用作激酶抑制剂的氨基嘧啶类化合物 | |
CN103079570A (zh) | 芳基或者杂芳基砜类用作治疗神经学上的功能失调的mglur4变构增效剂、组合物和方法 | |
JP2021525274A (ja) | ピリミジンシクロヘキセニル糖質コルチコイドレセプター調節因子 | |
Saraiva et al. | Synthesis and antitubercular evaluation of new fluoroquinolone derivatives coupled with carbohydrates | |
CN103492392B (zh) | 噻吩并[2,3-d]嘧啶衍生物及其用于治疗心律失常的用途 | |
CN110857304B (zh) | Trk抑制剂、其制备方法和用途 | |
CN103003273A (zh) | 吡唑并吡啶激酶抑制剂 | |
CN103827105A (zh) | 作为胆固醇酯转移蛋白(cetp)抑制剂的取代的杂环胺化合物 | |
US20080139608A1 (en) | 2,6,8, Trisubstituted 1-deazapurines and their different uses | |
JP2022514685A (ja) | ペンタミジンの類似体及びその使用 | |
CN103814025A (zh) | 可用作胆碱激酶抑制剂的化合物 | |
CN101258129A (zh) | 喹啉衍生物及其作为抗肿瘤剂的用途 | |
KR20150002952A (ko) | 피리도피리미딘 유도체를 함유하는 대사성 골 질환의 예방 및 치료용 약학 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1214589 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190425 Address after: 12th Floor of 56 Building No. 1000 Jinhai Road, China (Shanghai) Free Trade Pilot Area Co-patentee after: Jiangsu Ya Hong Pharmaceutical Technology Co., Ltd Patentee after: Shanghai Yahong Pharmaceutical Technology Co., Ltd. Address before: Virgin Islands of Tortola Patentee before: ASIERIS PHARMACEUTICAL TECHNOLOGIES CO., LTD. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 12 / F, building 56, 1000 Jinhai Road, China (Shanghai) pilot Free Trade Zone, 201203 Patentee after: Shanghai Yahong Pharmaceutical Technology Co.,Ltd. Patentee after: Jiangsu Yahong Pharmaceutical Technology Co.,Ltd. Address before: 12 / F, building 56, 1000 Jinhai Road, China (Shanghai) pilot Free Trade Zone, 201203 Patentee before: Shanghai Yahong Pharmaceutical Technology Co.,Ltd. Patentee before: JIANGSU YAHONG MEDICINE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |